Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA024538-07
Application #
4691047
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Klaich, G M; Kanter, P M (1995) Characterization of a monoclonal antibody recognizing a 138 kDa glioblastoma-associated antigen. Anticancer Drugs 6:45-52
Verstovsek, S; Eppolito, C; Ujhazy, P et al. (1995) Murine splenic macrophage tumoricidal activation by cytokines. Exp Hematol 23:519-28
Kanter, P M; Klaich, G M; Bullard, G A et al. (1994) Liposome encapsulated vincristine: preclinical toxicologic and pharmacologic comparison with free vincristine and empty liposomes in mice, rats and dogs. Anticancer Drugs 5:579-90
Ujhazy, P; Maccubbin, D; Eppolito, C et al. (1994) TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cells. Lymphokine Cytokine Res 13:99-106
Klaich, G M; Kanter, P M (1994) Induction of dog IL-1 by free and liposomal encapsulated doxorubicin. Anticancer Drugs 5:355-60
Ujhazy, P; Klobusicka, M; Babusikova, O et al. (1994) Ecto-5'-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin. Int J Cancer 59:83-93
Kanter, P M; Klaich, G; Bullard, G A et al. (1994) Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99) given intraperitoneally to dogs. In Vivo 8:975-82
Kanter, P M; Bullard, G A; King, J M (1994) Preclinical toxicologic evaluation of DENSPM (N1,N11-diethylnorspermine) in rats and dogs. Anticancer Drugs 5:448-56
Ho, R L; Maccubbin, D L; Ujhazy, P et al. (1993) Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma. Oncol Res 5:363-72
Kanter, P M; Bullard, G A; Pilkiewicz, F G et al. (1993) Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99): comparison with doxorubicin and empty liposomes in mice and dogs. In Vivo 7:85-95

Showing the most recent 10 out of 149 publications